TWI682997B - 用於改善插入序列傾向及增加ｄｎａ輸入耐受度之經修飾的轉位酶 - Google Patents
用於改善插入序列傾向及增加ｄｎａ輸入耐受度之經修飾的轉位酶 Download PDFInfo
- Publication number
- TWI682997B TWI682997B TW104112180A TW104112180A TWI682997B TW I682997 B TWI682997 B TW I682997B TW 104112180 A TW104112180 A TW 104112180A TW 104112180 A TW104112180 A TW 104112180A TW I682997 B TWI682997 B TW I682997B
- Authority
- TW
- Taiwan
- Prior art keywords
- transposase
- dna
- library
- mutation
- mutant
- Prior art date
Links
- 108010020764 Transposases Proteins 0.000 title claims abstract description 209
- 102000008579 Transposases Human genes 0.000 title claims abstract description 209
- 238000003780 insertion Methods 0.000 title abstract description 70
- 230000037431 insertion Effects 0.000 title abstract description 70
- 230000001965 increasing effect Effects 0.000 title description 27
- 238000000034 method Methods 0.000 claims abstract description 88
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 52
- 238000006243 chemical reaction Methods 0.000 claims abstract description 49
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 49
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 49
- 230000035772 mutation Effects 0.000 claims description 189
- 239000012634 fragment Substances 0.000 claims description 146
- 108010012306 Tn5 transposase Proteins 0.000 claims description 105
- 239000000872 buffer Substances 0.000 claims description 103
- 238000006467 substitution reaction Methods 0.000 claims description 82
- 108090000623 proteins and genes Proteins 0.000 claims description 64
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 36
- 230000000694 effects Effects 0.000 claims description 34
- 102000004169 proteins and genes Human genes 0.000 claims description 32
- 102000037865 fusion proteins Human genes 0.000 claims description 31
- 108020001507 fusion proteins Proteins 0.000 claims description 31
- 229920001184 polypeptide Polymers 0.000 claims description 31
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 31
- 238000012163 sequencing technique Methods 0.000 claims description 31
- 239000002773 nucleotide Substances 0.000 claims description 22
- 125000003729 nucleotide group Chemical group 0.000 claims description 22
- 230000004927 fusion Effects 0.000 claims description 19
- 230000005945 translocation Effects 0.000 claims description 19
- 239000013598 vector Substances 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 230000027455 binding Effects 0.000 claims description 15
- 239000004475 Arginine Substances 0.000 claims description 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 11
- 108091033319 polynucleotide Proteins 0.000 claims description 11
- 102000040430 polynucleotide Human genes 0.000 claims description 11
- 239000002157 polynucleotide Substances 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 9
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 8
- 239000013604 expression vector Substances 0.000 claims description 8
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 8
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 claims description 7
- 102000008300 Mutant Proteins Human genes 0.000 claims description 4
- 108010021466 Mutant Proteins Proteins 0.000 claims description 4
- 108010063460 elongation factor T Proteins 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000011535 reaction buffer Substances 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims 2
- 238000009395 breeding Methods 0.000 claims 1
- 230000001488 breeding effect Effects 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-M valinate Chemical compound CC(C)C(N)C([O-])=O KZSNJWFQEVHDMF-UHFFFAOYSA-M 0.000 claims 1
- 238000013467 fragmentation Methods 0.000 abstract description 14
- 238000006062 fragmentation reaction Methods 0.000 abstract description 14
- 108020004414 DNA Proteins 0.000 description 237
- 238000009826 distribution Methods 0.000 description 87
- 239000000203 mixture Substances 0.000 description 61
- 238000002372 labelling Methods 0.000 description 60
- 125000003275 alpha amino acid group Chemical group 0.000 description 39
- 238000000746 purification Methods 0.000 description 31
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 25
- 238000009472 formulation Methods 0.000 description 24
- 241000193755 Bacillus cereus Species 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 239000011324 bead Substances 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 20
- 231100000350 mutagenesis Toxicity 0.000 description 17
- 239000000523 sample Substances 0.000 description 16
- 230000006698 induction Effects 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- 150000001413 amino acids Chemical group 0.000 description 14
- 238000002741 site-directed mutagenesis Methods 0.000 description 14
- 108091092584 GDNA Proteins 0.000 description 13
- 239000011572 manganese Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 12
- 230000014509 gene expression Effects 0.000 description 12
- 108020004705 Codon Proteins 0.000 description 11
- 239000007995 HEPES buffer Substances 0.000 description 11
- 238000009396 hybridization Methods 0.000 description 11
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 10
- 150000001768 cations Chemical class 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 230000017105 transposition Effects 0.000 description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 9
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 9
- 235000011285 magnesium acetate Nutrition 0.000 description 9
- 239000011654 magnesium acetate Substances 0.000 description 9
- 229940069446 magnesium acetate Drugs 0.000 description 9
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 9
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 9
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 8
- 101000707471 Homo sapiens Serine incorporator 3 Proteins 0.000 description 8
- 102100031727 Serine incorporator 3 Human genes 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 229910017052 cobalt Inorganic materials 0.000 description 8
- 239000010941 cobalt Substances 0.000 description 8
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 8
- 239000013615 primer Substances 0.000 description 8
- 238000001742 protein purification Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 102000016470 mariner transposase Human genes 0.000 description 7
- 108060004631 mariner transposase Proteins 0.000 description 7
- 108010009127 mu transposase Proteins 0.000 description 7
- 239000007983 Tris buffer Substances 0.000 description 6
- 125000001165 hydrophobic group Chemical group 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 108010002459 HIV Integrase Proteins 0.000 description 5
- 241000405147 Hermes Species 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical group CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 210000003527 eukaryotic cell Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 102000012330 Integrases Human genes 0.000 description 4
- 108010061833 Integrases Proteins 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 102220483600 Troponin I, cardiac muscle_E54V_mutation Human genes 0.000 description 4
- 102220483514 Troponin I, cardiac muscle_L372P_mutation Human genes 0.000 description 4
- 102220483626 Troponin I, cardiac muscle_M56A_mutation Human genes 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 229910052721 tungsten Inorganic materials 0.000 description 4
- 238000007482 whole exome sequencing Methods 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- -1 brown) Proteins 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 210000002706 plastid Anatomy 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000012070 whole genome sequencing analysis Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 230000009946 DNA mutation Effects 0.000 description 2
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 2
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 2
- 125000003290 L-leucino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000003559 RNA-seq method Methods 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 102000023732 binding proteins Human genes 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 229910001429 cobalt ion Inorganic materials 0.000 description 2
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000012361 double-strand break repair Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000033607 mismatch repair Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000012900 molecular simulation Methods 0.000 description 2
- 229910001453 nickel ion Inorganic materials 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 108020001580 protein domains Proteins 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000013643 reference control Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000006257 total synthesis reaction Methods 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000034286 G proteins Human genes 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 102000006612 Transducin Human genes 0.000 description 1
- 108010087042 Transducin Proteins 0.000 description 1
- 108010028230 Trp-Ser- His-Pro-Gln-Phe-Glu-Lys Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 238000012219 cassette mutagenesis Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000004094 preconcentration Methods 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 238000001814 protein method Methods 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108010066533 ribonuclease S Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000004358 rod cell outer segment Anatomy 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 101150091813 shfl gene Proteins 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1068—Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461979871P | 2014-04-15 | 2014-04-15 | |
| US61/979,871 | 2014-04-15 | ||
| US201462062006P | 2014-10-09 | 2014-10-09 | |
| US62/062,006 | 2014-10-09 | ||
| US201462080882P | 2014-11-17 | 2014-11-17 | |
| US62/080,882 | 2014-11-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201621048A TW201621048A (zh) | 2016-06-16 |
| TWI682997B true TWI682997B (zh) | 2020-01-21 |
Family
ID=53008897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW104112180A TWI682997B (zh) | 2014-04-15 | 2015-04-15 | 用於改善插入序列傾向及增加ｄｎａ輸入耐受度之經修飾的轉位酶 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US9790476B2 (enExample) |
| EP (2) | EP3845640A3 (enExample) |
| JP (1) | JP6490710B2 (enExample) |
| CN (3) | CN106507677B (enExample) |
| AU (3) | AU2015247779B2 (enExample) |
| CA (1) | CA2946046A1 (enExample) |
| SG (1) | SG11201608585RA (enExample) |
| TW (1) | TWI682997B (enExample) |
| WO (1) | WO2015160895A2 (enExample) |
Families Citing this family (134)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| CA2881685C (en) | 2012-08-14 | 2023-12-05 | 10X Genomics, Inc. | Microcapsule compositions and methods |
| US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| WO2014093676A1 (en) | 2012-12-14 | 2014-06-19 | 10X Technologies, Inc. | Methods and systems for processing polynucleotides |
| US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| EP3862435A1 (en) | 2013-02-08 | 2021-08-11 | 10X Genomics, Inc. | Polynucleotide barcode generation |
| CN105849275B (zh) | 2013-06-25 | 2020-03-17 | 普罗格诺西斯生物科学公司 | 检测样品中生物靶标的空间分布的方法和系统 |
| US9694361B2 (en) | 2014-04-10 | 2017-07-04 | 10X Genomics, Inc. | Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same |
| EP3845640A3 (en) | 2014-04-15 | 2021-09-01 | Illumina, Inc. | Modified tranposases for improved insertion sequence bias and increased dna input tolerence |
| AU2015273232B2 (en) | 2014-06-13 | 2021-09-16 | Illumina Cambridge Limited | Methods and compositions for preparing sequencing libraries |
| CA2953469A1 (en) | 2014-06-26 | 2015-12-30 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| US12312640B2 (en) | 2014-06-26 | 2025-05-27 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| AU2015279548B2 (en) | 2014-06-26 | 2020-02-27 | 10X Genomics, Inc. | Methods of analyzing nucleic acids from individual cells or cell populations |
| ES2713153T3 (es) | 2014-06-30 | 2019-05-20 | Illumina Inc | Métodos y composiciones que utilizan la transposición unilateral |
| KR20170073667A (ko) | 2014-10-29 | 2017-06-28 | 10엑스 제노믹스, 인크. | 표적화 핵산 서열 분석을 위한 방법 및 조성물 |
| US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
| DK3215618T3 (da) * | 2014-11-05 | 2019-10-14 | Illumina Inc | Transposasesammensætninger til reduktion af insertionsbias |
| US10900065B2 (en) | 2014-11-14 | 2021-01-26 | University Of Washington | Methods and kits for labeling cellular molecules |
| SG11201705615UA (en) | 2015-01-12 | 2017-08-30 | 10X Genomics Inc | Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same |
| EP3259355B1 (en) | 2015-02-20 | 2020-11-25 | The Regents of the University of California | Methods related to dna sequencing |
| EP3262407B1 (en) | 2015-02-24 | 2023-08-30 | 10X Genomics, Inc. | Partition processing methods and systems |
| MX2017010857A (es) | 2015-02-24 | 2017-12-11 | 10X Genomics Inc | Metodos para la cobertura de secuencia de acidos nucleicos seleccionados como diana. |
| EP4119677B1 (en) | 2015-04-10 | 2023-06-28 | Spatial Transcriptomics AB | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
| EP3303584B1 (en) | 2015-05-29 | 2019-10-09 | Epicentre Technologies Corporation | Methods of analyzing nucleic acids |
| CN108431232B (zh) | 2015-12-04 | 2022-10-14 | 10X 基因组学有限公司 | 用于核酸分析的方法和组合物 |
| WO2017156336A1 (en) * | 2016-03-10 | 2017-09-14 | The Board Of Trustees Of The Leland Stanford Junior University | Transposase-mediated imaging of the accessible genome |
| JP7022699B2 (ja) * | 2016-04-19 | 2022-02-18 | カパ バイオシステムズ， インコーポレイテッド | トランスポザーゼ競合物制御系 |
| WO2017197343A2 (en) | 2016-05-12 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic on-chip filters |
| WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
| CN106222164B (zh) * | 2016-07-28 | 2020-04-21 | 元码基因科技（北京）股份有限公司 | 利用转座子酶进行体外核酸单向扩增的方法、组合物和试剂盒 |
| EP4435116A3 (en) | 2016-08-05 | 2024-12-18 | Bio-Rad Laboratories, Inc. | Second strand direct |
| EP3553180B1 (en) * | 2016-12-07 | 2022-05-04 | MGI Tech Co., Ltd. | Method for constructing single cell sequencing library and use thereof |
| WO2018118971A1 (en) | 2016-12-19 | 2018-06-28 | Bio-Rad Laboratories, Inc. | Droplet tagging contiguity preserved tagmented dna |
| CN106754811B (zh) * | 2016-12-21 | 2019-05-14 | 南京诺唯赞生物科技有限公司 | 一种突变型Tn5转座酶及其制备方法和应用 |
| US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| CN106801044B (zh) * | 2017-01-09 | 2021-03-23 | 北京全式金生物技术有限公司 | 一种环状转座子复合物及其应用 |
| US12264411B2 (en) | 2017-01-30 | 2025-04-01 | 10X Genomics, Inc. | Methods and systems for analysis |
| EP3545089B1 (en) | 2017-01-30 | 2022-03-09 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
| EP3452621B1 (en) | 2017-02-21 | 2022-09-21 | Illumina Inc. | Tagmentation using immobilized transposomes with linkers |
| US10400235B2 (en) | 2017-05-26 | 2019-09-03 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
| CN116064732A (zh) | 2017-05-26 | 2023-05-05 | 10X基因组学有限公司 | 转座酶可接近性染色质的单细胞分析 |
| JP7402156B2 (ja) * | 2017-08-30 | 2023-12-20 | カパ バイオシステムズ， インコーポレイテッド | トランスポザーゼ組成物、製造方法およびスクリーニング方法 |
| DK4339298T3 (da) * | 2017-09-25 | 2025-12-08 | Fred Hutchinson Cancer Center | Højeffektiv, in situ-målrettet genom-bred profilering |
| WO2019084043A1 (en) | 2017-10-26 | 2019-05-02 | 10X Genomics, Inc. | METHODS AND SYSTEMS FOR NUCLEIC ACID PREPARATION AND CHROMATIN ANALYSIS |
| CN111295443B (zh) | 2017-11-02 | 2024-04-16 | 生物辐射实验室股份有限公司 | 基于转座酶的基因组分析 |
| SG11201913654QA (en) | 2017-11-15 | 2020-01-30 | 10X Genomics Inc | Functionalized gel beads |
| US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
| CN119020348A (zh) | 2018-02-05 | 2024-11-26 | 斯坦福大学托管董事会 | 用于单细胞和集合细胞的多重测量的系统和方法 |
| CN108285494B (zh) * | 2018-02-11 | 2021-09-07 | 北京大学 | 一种融合蛋白、试剂盒以及CHIP-seq检测方法 |
| WO2019157529A1 (en) | 2018-02-12 | 2019-08-15 | 10X Genomics, Inc. | Methods characterizing multiple analytes from individual cells or cell populations |
| WO2019184044A1 (zh) * | 2018-03-27 | 2019-10-03 | 上海欣百诺生物科技有限公司 | 一种转座酶-抗体结合蛋白的融合蛋白及其制备与应用 |
| EP3775271B1 (en) | 2018-04-06 | 2025-03-12 | 10X Genomics, Inc. | Systems and methods for quality control in single cell processing |
| US11932899B2 (en) | 2018-06-07 | 2024-03-19 | 10X Genomics, Inc. | Methods and systems for characterizing nucleic acid molecules |
| CN108913712B (zh) * | 2018-07-17 | 2021-04-02 | 厦门生命互联科技有限公司 | 一种重组Tn5转座酶的表达纯化方法 |
| EP3830289A1 (en) | 2018-08-03 | 2021-06-09 | 10X Genomics, Inc. | Methods and systems to minimize barcode exchange |
| EP4249651B1 (en) | 2018-08-20 | 2025-01-29 | Bio-Rad Laboratories, Inc. | Nucleotide sequence generation by barcode bead-colocalization in partitions |
| US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
| MX2021003771A (es) | 2018-11-30 | 2021-05-27 | Illumina Inc | Analisis de analitos multiples usando un ensayo unico. |
| US12385083B2 (en) | 2018-12-10 | 2025-08-12 | 10X Genomics, Inc. | Methods of using master / copy arrays for spatial detection |
| CN112867800B (zh) | 2018-12-17 | 2024-07-12 | Illumina公司 | 用于制备测序文库的方法和手段 |
| US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11845983B1 (en) | 2019-01-09 | 2023-12-19 | 10X Genomics, Inc. | Methods and systems for multiplexing of droplet based assays |
| WO2020144373A1 (en) | 2019-01-11 | 2020-07-16 | Illumina Cambridge Limited | Complex surface-bound transposome complexes |
| US11467153B2 (en) | 2019-02-12 | 2022-10-11 | 10X Genomics, Inc. | Methods for processing nucleic acid molecules |
| WO2020167866A1 (en) | 2019-02-12 | 2020-08-20 | 10X Genomics, Inc. | Systems and methods for transposon loading |
| EP3924505B1 (en) | 2019-02-12 | 2025-12-17 | 10X Genomics, Inc. | Methods for processing nucleic acid molecules |
| AU2020266530A1 (en) | 2019-04-29 | 2021-04-08 | Illumina, Inc. | Identification and analysis of microbial samples by rapid incubation and nucleic acid enrichment |
| EP3976820A1 (en) | 2019-05-30 | 2022-04-06 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| SG11202105834UA (en) | 2019-07-12 | 2021-07-29 | Illumina Cambridge Ltd | Nucleic acid library preparation using electrophoresis |
| WO2021092433A2 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
| CN110938610B (zh) * | 2019-12-16 | 2020-12-01 | 广东菲鹏生物有限公司 | 一种转座酶突变体、融合蛋白、其制备方法和应用 |
| WO2021133842A1 (en) | 2019-12-23 | 2021-07-01 | 10X Genomics, Inc. | Compositions and methods for using fixed biological samples in partition-based assays |
| ES2946357T3 (es) | 2019-12-23 | 2023-07-17 | 10X Genomics Inc | Métodos para el análisis espacial usando ligación con molde de ARN |
| US12365942B2 (en) | 2020-01-13 | 2025-07-22 | 10X Genomics, Inc. | Methods of decreasing background on a spatial array |
| US12405264B2 (en) | 2020-01-17 | 2025-09-02 | 10X Genomics, Inc. | Electrophoretic system and method for analyte capture |
| US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
| US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
| US20210230681A1 (en) | 2020-01-24 | 2021-07-29 | 10X Genomics, Inc. | Methods for spatial analysis using proximity ligation |
| US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
| US12110541B2 (en) | 2020-02-03 | 2024-10-08 | 10X Genomics, Inc. | Methods for preparing high-resolution spatial arrays |
| US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
| US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
| US12129516B2 (en) | 2020-02-07 | 2024-10-29 | 10X Genomics, Inc. | Quantitative and automated permeabilization performance evaluation for spatial transcriptomics |
| US12281357B1 (en) | 2020-02-14 | 2025-04-22 | 10X Genomics, Inc. | In situ spatial barcoding |
| US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
| ES2965354T3 (es) | 2020-04-22 | 2024-04-12 | 10X Genomics Inc | Métodos para análisis espacial que usan eliminación de ARN elegido como diana |
| EP4153775B1 (en) | 2020-05-22 | 2024-07-24 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
| EP4553168A3 (en) | 2020-05-22 | 2025-08-27 | 10x Genomics, Inc. | Spatial analysis to detect sequence variants |
| US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
| WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
| CN116034166A (zh) | 2020-06-25 | 2023-04-28 | 10X基因组学有限公司 | Dna甲基化的空间分析 |
| US12209280B1 (en) | 2020-07-06 | 2025-01-28 | 10X Genomics, Inc. | Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis |
| US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
| US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
| JP2023543541A (ja) | 2020-08-06 | 2023-10-17 | イルミナ インコーポレイテッド | ビーズ連結トランスポソームを使用するｒｎａ及びｄｎａ配列決定ライブラリの調製 |
| EP4200416A1 (en) | 2020-08-18 | 2023-06-28 | Illumina, Inc. | Sequence-specific targeted transposition and selection and sorting of nucleic acids |
| US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
| CN112164419A (zh) * | 2020-09-04 | 2021-01-01 | 云舟生物科技（广州）有限公司 | 在orf中插入蛋白标签的方法以及计算机存储介质 |
| EP4211238A4 (en) * | 2020-09-11 | 2024-09-18 | Fred Hutchinson Cancer Center | IMPROVED HIGHLY EFFICIENT TARGETED GENOME-WIDE IN-SITU PROFILING |
| US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| MX2023004461A (es) | 2020-10-21 | 2023-05-03 | Illumina Inc | Plantillas de secuenciacion que comprenden multiples insertos y composiciones y metodos para mejorar la productividad de secuenciacion. |
| US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
| AU2021409136A1 (en) | 2020-12-21 | 2023-06-29 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
| US20240093290A1 (en) | 2021-01-29 | 2024-03-21 | 10X Genomics, Inc. | Method for transposase mediated spatial tagging and analyzing genomic dna in a biological sample |
| EP4288534A1 (en) * | 2021-02-05 | 2023-12-13 | Ospedale San Raffaele S.r.l. | Engineered transposase and uses thereof |
| CN112795563A (zh) * | 2021-03-23 | 2021-05-14 | 上海欣百诺生物科技有限公司 | 生物素化的转座体在回收CUT&Tag或ATAC-seq产物中的用途及方法 |
| MX2023010814A (es) | 2021-03-29 | 2023-09-27 | Illumina Inc | Metodos mejorados de preparacion de genotecas. |
| EP4314282A1 (en) | 2021-03-30 | 2024-02-07 | Illumina, Inc. | Improved methods of isothermal complementary dna and library preparation |
| EP4314283A1 (en) | 2021-03-31 | 2024-02-07 | Illumina, Inc. | Methods of preparing directional tagmentation sequencing libraries using transposon-based technology with unique molecular identifiers for error correction |
| EP4428246B1 (en) | 2021-04-14 | 2025-12-24 | 10X Genomics, Inc. | Methods of measuring mislocalization of an analyte |
| WO2022233821A1 (en) * | 2021-05-03 | 2022-11-10 | European Molecular Biology Laboratory | Methods for isolating and/or obtaining captured polynucleotide fragments |
| WO2022236054A1 (en) | 2021-05-06 | 2022-11-10 | 10X Genomics, Inc. | Methods for increasing resolution of spatial analysis |
| WO2022256503A1 (en) | 2021-06-03 | 2022-12-08 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
| EP4509614A3 (en) | 2021-09-01 | 2025-05-14 | 10X Genomics, Inc. | Methods, compositions, and kits for blocking a capture probe on a spatial array |
| EP4419707A1 (en) | 2021-11-10 | 2024-08-28 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of an analyte in a biological sample |
| WO2023102118A2 (en) | 2021-12-01 | 2023-06-08 | 10X Genomics, Inc. | Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis |
| CN114807084B (zh) * | 2022-04-26 | 2023-05-16 | 翌圣生物科技(上海)股份有限公司 | 突变型Tn5转座酶及试剂盒 |
| WO2023225519A1 (en) | 2022-05-17 | 2023-11-23 | 10X Genomics, Inc. | Modified transposons, compositions and uses thereof |
| CN115927244B (zh) * | 2022-05-26 | 2026-01-02 | 上海墨卓生物科技有限公司 | 一种基于微流控技术的单细胞ChIP-seq文库的构建方法 |
| CN115948363B (zh) * | 2022-08-26 | 2024-02-27 | 武汉影子基因科技有限公司 | Tn5转座酶突变体及其制备方法和应用 |
| CN115785283B (zh) * | 2022-11-02 | 2024-05-31 | 武汉影子基因科技有限公司 | PAG-Tn5突变体及其应用 |
| WO2024137934A1 (en) * | 2022-12-21 | 2024-06-27 | The Trustees Of Columbia University In The City Of New York | Use of pa-tn5 to generate dna libraries |
| WO2025137479A1 (en) | 2023-12-22 | 2025-06-26 | Illumina, Inc. | Reusable flow cells and methods of using them for nucleic acid sequencing |
| WO2025244841A1 (en) | 2024-05-23 | 2025-11-27 | Illumina, Inc. | Methods and systems for quantifying targeted enrichment efficiency |
| WO2026006746A2 (en) | 2024-06-28 | 2026-01-02 | Illumina, Inc. | Nucleic acid preparation and analysis techniques |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5677170A (en) | 1994-03-02 | 1997-10-14 | The Johns Hopkins University | In vitro transposition of artificial transposons |
| US5925545A (en) | 1996-09-09 | 1999-07-20 | Wisconsin Alumni Research Foundation | System for in vitro transposition |
| US5965443A (en) | 1996-09-09 | 1999-10-12 | Wisconsin Alumni Research Foundation | System for in vitro transposition |
| US6159736A (en) * | 1998-09-23 | 2000-12-12 | Wisconsin Alumni Research Foundation | Method for making insertional mutations using a Tn5 synaptic complex |
| PL353241A1 (en) * | 1999-08-02 | 2003-11-03 | Wisconsin Alumni Research Foundation | Mutant tn5 transposase enzymes and method for their use |
| US7262056B2 (en) * | 2001-11-08 | 2007-08-28 | Mirus Bio Corporation | Enhancing intermolecular integration of nucleic acids using integrator complexes |
| US7083980B2 (en) * | 2003-04-17 | 2006-08-01 | Wisconsin Alumni Research Foundation | Tn5 transposase mutants and the use thereof |
| US7608434B2 (en) * | 2004-08-04 | 2009-10-27 | Wisconsin Alumni Research Foundation | Mutated Tn5 transposase proteins and the use thereof |
| KR100890187B1 (ko) | 2007-09-06 | 2009-03-25 | 고려대학교 산학협력단 | Ｔｓｆ를 융합파트너로 이용한 재조합 단백질의 제조방법 |
| US9080211B2 (en) * | 2008-10-24 | 2015-07-14 | Epicentre Technologies Corporation | Transposon end compositions and methods for modifying nucleic acids |
| HUE027961T2 (en) | 2008-10-24 | 2016-11-28 | Epicentre Tech Corp | Transposon final preparations and methods for modifying nucleic acids |
| US9005935B2 (en) | 2011-05-23 | 2015-04-14 | Agilent Technologies, Inc. | Methods and compositions for DNA fragmentation and tagging by transposases |
| WO2013085918A1 (en) | 2011-12-05 | 2013-06-13 | The Regents Of The University Of California | Methods and compostions for generating polynucleic acid fragments |
| EP3845640A3 (en) | 2014-04-15 | 2021-09-01 | Illumina, Inc. | Modified tranposases for improved insertion sequence bias and increased dna input tolerence |
-
2015
- 2015-04-15 EP EP20208323.4A patent/EP3845640A3/en active Pending
- 2015-04-15 SG SG11201608585RA patent/SG11201608585RA/en unknown
- 2015-04-15 CN CN201580027103.XA patent/CN106507677B/zh active Active
- 2015-04-15 TW TW104112180A patent/TWI682997B/zh active
- 2015-04-15 EP EP15719091.9A patent/EP3132029A2/en active Pending
- 2015-04-15 JP JP2016562588A patent/JP6490710B2/ja active Active
- 2015-04-15 CN CN202110295229.2A patent/CN113005108B/zh active Active
- 2015-04-15 WO PCT/US2015/025889 patent/WO2015160895A2/en not_active Ceased
- 2015-04-15 US US14/686,961 patent/US9790476B2/en active Active
- 2015-04-15 AU AU2015247779A patent/AU2015247779B2/en active Active
- 2015-04-15 CN CN202510139371.6A patent/CN120098956A/zh active Pending
- 2015-04-15 CA CA2946046A patent/CA2946046A1/en active Pending
-
2017
- 2017-10-12 US US15/782,757 patent/US10035992B2/en active Active
-
2018
- 2018-06-28 US US16/021,417 patent/US10385323B2/en active Active
-
2019
- 2019-04-29 US US16/397,542 patent/US10544403B2/en active Active
-
2021
- 2021-09-22 AU AU2021236488A patent/AU2021236488B2/en active Active
-
2024
- 2024-07-24 AU AU2024205075A patent/AU2024205075A1/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| Ason B and Reznikoff WS, "DNA sequence bias during Tn5 transposition", J. Mol. Biol., 335(5):1213-1225, 2004/01/30 |
| Gradman RJ et al., "A bifunctional DNA binding region in Tn5 transposase", Molecular Microbiology 67(3), 528–540, 2007/12/16 |
| Gradman RJ et al., "A bifunctional DNA binding region in Tn5 transposase", Molecular Microbiology 67(3), 528–540, 2007/12/16 Ason B and Reznikoff WS, "DNA sequence bias during Tn5 transposition", J. Mol. Biol., 335(5):1213-1225, 2004/01/30 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015160895A3 (en) | 2016-01-14 |
| US9790476B2 (en) | 2017-10-17 |
| AU2024205075A1 (en) | 2024-10-03 |
| US20190359955A1 (en) | 2019-11-28 |
| AU2015247779B2 (en) | 2021-06-24 |
| CN113005108B (zh) | 2025-02-11 |
| JP2017513479A (ja) | 2017-06-01 |
| AU2021236488B2 (en) | 2024-06-20 |
| EP3132029A2 (en) | 2017-02-22 |
| EP3845640A2 (en) | 2021-07-07 |
| CN120098956A (zh) | 2025-06-06 |
| US20180298356A1 (en) | 2018-10-18 |
| AU2015247779A1 (en) | 2016-11-03 |
| CN113005108A (zh) | 2021-06-22 |
| AU2021236488A1 (en) | 2021-10-21 |
| US10385323B2 (en) | 2019-08-20 |
| EP3845640A3 (en) | 2021-09-01 |
| US10544403B2 (en) | 2020-01-28 |
| WO2015160895A2 (en) | 2015-10-22 |
| CN106507677A (zh) | 2017-03-15 |
| US20150291942A1 (en) | 2015-10-15 |
| US20180171311A1 (en) | 2018-06-21 |
| JP6490710B2 (ja) | 2019-03-27 |
| US10035992B2 (en) | 2018-07-31 |
| SG11201608585RA (en) | 2016-11-29 |
| CN106507677B (zh) | 2021-03-12 |
| CA2946046A1 (en) | 2015-10-22 |
| TW201621048A (zh) | 2016-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI682997B (zh) | 用於改善插入序列傾向及增加ｄｎａ輸入耐受度之經修飾的轉位酶 | |
| JP6397612B2 (ja) | Ｄｎａ断片化および標的化のための固定化されたトランスポザーゼ複合体 | |
| CN113811608B (zh) | 毛螺菌科细菌nd2006 cas12a突变型基因和由其编码的多肽 | |
| JP6879519B2 (ja) | リコンビナーゼ変異体 | |
| HK40055417A (en) | Modified transposases for improved insertion sequence bias and increased dna input tolerance | |
| HK40055417B (zh) | 用於改进插入序列偏倚和增加dna输入耐受性的修饰的转座酶 | |
| Lawrie et al. | A high throughput approach for the generation of orthogonally interacting protein pairs | |
| HK40049185A (en) | Modified transposases for improved insertion sequence bias and increased dna input tolerance | |
| WO2026015421A1 (en) | Efficient genome editing with chimeric oligonucleotide-directed editing | |
| WO2025049563A1 (en) | A programmable gene correction technology using cas-polymerase constructs | |
| TW202536172A (zh) | 改變型ｒｎａ聚合酶、多核苷酸、載體、重組宿主細胞、製造ｒｎａ聚合酶之方法、試劑、ｒｎａ合成方法、以及合成ｒｎａ醫藥之方法 | |
| WO2004101783A1 (fr) | Methode d'utilisation d'une sequence d'adn cible | |
| HK1235066B (en) | Recombinase mutants | |
| HK1235066A1 (en) | Recombinase mutants |